產(chǎn)品名稱

Tacalcitol - PRI 2191 | 1α,24-Dihydroxycholecalciferol

產(chǎn)品貨號(hào)

Axon 2516 CAS [57333-96-7] MF C27H44O3MW 416.64 Purity: 98% Soluble in DMSO Description Vitamine D receptor agonist (EC50 value 7 nM for VDR) and metabolite of vitamin D3 with a higher antitumor and lower calcemic activity as well as lower toxicity than Calcitriol. Tacalcitol inhibits proliferation and induces differentiation of keratinocytes. Tacalcitol (PRI 2191) promotes normal bone formation, and is a well-known inhibitor of chemical mediated inflammatory changes including dermal cellular infiltration and epidermal hyperplasia, used to treat T cell-mediated inflammatory skin diseases such as psoriasis, prurigo and vitiligo. PRI2191 enhances the antiproliferative effect of Imatinib (Axon 1394) on HL-60 cells. Note:

產(chǎn)品價(jià)格

現(xiàn)貨詢價(jià)，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

Tacalcitol - PRI 2191 | 1α,24-Dihydroxycholecalciferol

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 2516

CAS [57333-96-7]

MF C27H44O3
MW 416.64

Purity: 98%
Soluble in DMSO

Tacalcitol

Description

Vitamine D receptor agonist (EC50 value 7 nM for VDR) and metabolite of vitamin D3 with a higher antitumor and lower calcemic activity as well as lower toxicity than Calcitriol. Tacalcitol inhibits proliferation and induces differentiation of keratinocytes. Tacalcitol (PRI 2191) promotes normal bone formation, and is a well-known inhibitor of chemical mediated inflammatory changes including dermal cellular infiltration and epidermal hyperplasia, used to treat T cell-mediated inflammatory skin diseases such as psoriasis, prurigo and vitiligo. PRI2191 enhances the antiproliferative effect of Imatinib (Axon 1394) on HL-60 cells.

Note: Axon 2516 is the stable monohydrate formulation of Tacalcitol

J. Wietrzyk et al. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191). Steroids. 2004 Sep;69(10):629-35.

A. Opolski et al. Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines. Anticancer Res. 1999 Nov-Dec;19(6B):5217-22.

W. Shen et al. Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton. Eur J Med Chem. 2013 Nov;69:768-78.

Certificate of Analysis
Material Safety Data Sheet

Apoptosis Cell Signaling & Oncology Pain & Inflammation Endocrinology MAPK PI3K-Akt-mTOR VDR NR1I

Vitamine D receptor (VDR) agonist with antitumor activity

Chemical name

(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

Parent CAS No.

[57333-96-7]

產(chǎn)品資料